Anti-inflammatory and antioxidant mechanisms of urolithin B in activated microglia

Phytomedicine

Volumn 55, Issue , 2019, Pages 50-57

  Lee, Gyeongjin ^a   Park, Jin Sun ^a   Lee, Eun Jung ^a   Ahn, Jung Hyuck ^a   Kim, Hee Sun ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Anti inflammatory; Antioxidant; Microglia; Molecular mechanisms; Neuroinflammation; Urolithin B

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYCLOOXYGENASE 2; GLYCOPROTEIN GP 91; HEME OXYGENASE 1; I KAPPA B KINASE ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN KINASE B; PROTEIN P22; PROTEIN P47; PROTEIN P67; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UROLITHIN B; COUMARIN DERIVATIVE; CYTOKINE; HMOX1 PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; NOS2 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BV-2 CELL LINE; CELL ACTIVATION; CYTOKINE PRODUCTION; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BRAIN; CELL LINE; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BRAIN; CELL LINE; COUMARINS; CYCLOOXYGENASE 2; CYTOKINES; HEME OXYGENASE-1; LIPOPOLYSACCHARIDES; MALE; MEMBRANE PROTEINS; MICE, INBRED ICR; MICROGLIA; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 85055888025     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2018.06.032     Document Type: Article

References (26)

1. Barnes, P.J., Karin, M., Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:15 (1997), 1066–1071.
2. Bocchini, V., Mazzolla, R., Barluzzi, R., Blasi, E., Sick, P., Kettenmann, H., An immortalized cell line expresses properties of activated microglial cells. J. Neurosci. Res. 31 (1992), 616–621.
3. Cherry, J.D., Olschowka, J.A., O'Banion, M.K., Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J. Neuroinflammation, 11, 2014, 98.
4. Cuadrado, A., Rojo, A.I., Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections. Curr. Pharm. Des. 14 (2008), 429–442.
5. Gasperotti, M., Passamonti, S., Tramer, F., Masuero, D., Guella, G., Mattivi, F., Vrhovsek, U., Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination? ACS Chem. Neuroscience 6 (2015), 1341–1352.
6. Giri, S., Nath, N., Smith, B., Viollet, B., Singh, A.K., Singh, I., 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside inhibits proinflammatory response in glial cells: A possible role of AMPK-activated protein kinase. J. Neurosci. 24 (2004), 479–487.
7. González-Sarrías, A., Larrosa, M., Tomás-Barberán, F.A., Dolara, P., Espín, J.C., NF-κB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br. J. Nutri. 104 (2010), 503–512.
8. Henning, S.M., Seeram, N.P., Zhang, Y., Li, L., Gao, K., Lee, R.P., Wang, D.C., Zerlin, A., Karp, H., Thames, G., Kotlerman, J., Heber, D., Strawberry consumption is associated with increased antioxidant capacity in serum. J. Med. Food 13:1 (2010), 116–122.
9. Ito, M., Metabolites of the ellagitannin geraniin and their antioxidant activities. Planta Med. 77 (2011), 1110–1115.
10. Kaminska, B., MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 1754 (2005), 253–262.
11. Kang, C.H., Jayasooriya, R.G., Dilshara, M.G., Choi, Y.H., Jeong, Y.K., Kim, N.D., Kim, G.Y., Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-κB activation and ERK phosphorylation. Food Chem. Toxicol. 50:12 (2012), 4270–4276.
12. Landete, J.M., Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health. Food Res. Int. 44 (2011), 1150–1160.
13. Lee, E.J., Ko, H.M., Jeong, Y.H., Park, E.M., Kim, H.S., β-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia. J. Neuroinflammation, 12, 2015, 133.
14. Lee, Y.Y., Park, J.S., Lee, E.J., Lee, S.Y., Kim, D.H., Kang, J.L., Kim, H.S., Anti-inflammatory mechanism of ginseng saponin metabolite Rh3 in lipopolysaccharide-stimulated microglia: critical role of 5-adenosine monophosphate-activated protein kinase signaling pathway. J. Agric. Food Chem. 63 (2015), 3472–3480.
15. Meares, G.P., Qin, H., Liu, Y., Holdbrooks, A.T., Benveniste, E.N., AMP-activated protein kinase (AMPK) restricts IFN-γ signaling. J. Immunol. 190 (2012), 372–380.
16. Mele, L., Mena, P., Piemontese, A., Marino, V., López-Gutiérrez, N., Bernini, F., Brighenti, F., Zanotti, I., Del Rio, D., Antiatherogenic effects of ellagic acid and urolithins in vitro. Arch. Biochem. Biophys. 599 (2016), 42–50.
17. Mittal, M., Siddiqui, M.R., Tran, K., Reddy, S.P., Malik, A.B., Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20 (2014), 1126–1167.
18. Okuda, T., Yoshida, T., Hatano, T., Ellagitannins as active constituents of medicinal plants. Planta Med. 55 (1989), 117–122.
19. Piwowarski, J.P., Kiss, A.K., Granica, S., Moeslinger, T., Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages. Mol. Nutr. Food Res. 59 (2015), 2168–2177.
20. Prinz, M., Priller, J., Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15 (2014), 300–312.
21. Ransohoff, R.M., How neuroinflammation contributes to neurodegeneration. Science 353 (2016), 777–782.
22. Reddy, M.K., Gupta, S.K., Jacob, M.R., Khan, S.I., Ferreira, D., Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med. 73:5 (2007), 461–467.
23. Ryoo, I.G., Kim, G., Choi, B.H., Lee, S.H., Kwak, M.K., Involvement of Nrf2 signaling in doxorubicin resistance of cancer stem cell-enriched colonospheres. Biomol. Ther. 24 (2016), 482–488.
24. Tomás-Barberán, F.A., González-Sarrías, A., García-Villalba, R., Núñez-Sánchez, M.A., Selma, M.V., García-Conesa, M.T., Espín, J.C., Urolithins, the rescue of “old” metabolites to understand a “new” concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Mol. Nutr. Food Res., 61, 2017, 1500901.
25. Tremblay, M.È., Stevens, B., Sierra, A., Wake, H., Bessis, A., Nimmerjahn, A., The role of microglia in the healthy brain. J. Neurosci. 31 (2011), 16064–16069.
26. Yuan, T., Ma, H., Liu, W., Niesen, D.B., Shah, N., Crews, R., Rose, K.N., Vattem, D.A., Seeram, N.P., Pomegranate's neuroprotective effects against Alzheimer's disease are mediated by urolithins, its ellagitannin-gut microbial derived metabolites. ACS Chem. Neurosci. 7 (2016), 26–33.